✦ LIBER ✦

Chemoprevention and therapy of mouse mammary carcinomas with doxorubicin encapsulated in sterically stabilized liposomes

✍ Scribed by Jan Vaage; Dorothy Donovan; Tamora Loftus; Robert Abra; Peter Working; Anthony Huang

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 466 KB
Volume: 73
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19940501)73:9<2366::aid-cncr2820730920>3.0.co;2-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapy of mouse mammary carcinomas with

Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes

✍ Jan Vaage; Dorothy Donovan; Eric Mayhew; Paul Uster; Martin Woodle 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 431 KB

Therapy of primary and metastatic mouse

Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes

✍ Jan Vaage; Eric Mayhew; Dan Lasic; Frank Martin 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 639 KB

The purpose of our study was to compare the therapeutic effects of doxorubicin in 3 different formulations: (I) in PBS, (2) in conventional liposomes composed of egg phosphatidylglycerol/ egg phosphatidylcholine/cholesterol/dl-a tocopherol, and (3) in sterically stabilized, long-circulating "Stealth

Therapy of human ovarian carcinoma xenog

Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes

✍ Jan Vaage; Dorothy Donovan; Eric Mayhew; Robert Abra; Anthony Huang 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB

Background. This study compared the therapeutic effects of doxorubicin hydrochloride in saline and in sterically stabilized, long-circulating liposomes composed of hydrogenated soy phosphatidylcholine/cholesteroljpolyethylene glycol-distearoyl-phosphatidyl-ethanolamine (Doxil]. Methods. The drug fo

Inhibition of mouse mammary carcinoma de

Inhibition of mouse mammary carcinoma development with doxorubicin in liposomes

✍ Jan Vaage; Peter Working; Paul Uster 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 35 KB

Monthly treatments with intravenous doxorubicin encapsulated in long circulating, sterically stabilized liposomes delayed the appearance of primary mammary carcinomas and reduced the final incidence from 49 in 50 untreated mice to 46 in 87 treated mice. No toxic side effects of the treatments were o

Liposome-encapsulated doxorubicin compar

Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma

✍ Lyndsay Harris; Gerald Batist; Robert Belt; Douglas Rovira; Rudolph Navari; Noza 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Intracellular delivery of doxorubicin wi

Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: In vitro and in vivo

✍ Xiao-Bing Xiong; Yue Huang; Wan-Liang LU; Xuan Zhang; Hua Zhang; Tsuneji Nagai; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

Passive targeting by sterically stabilized liposomes (SSL), once combined with efficient intracellular delivery, may be a very useful strategy to improve the antitumor efficacy for the anticancer agents. The arginine-glycine-aspartic acid tripeptide (RGD) is known to serve as a recognition motif for